79
The results could reinforce the dominance of Eli Lilly and Novo Nordisk in the booming market for weight loss and diabetes drugs.Original Article
The results could reinforce the dominance of Eli Lilly and Novo Nordisk in the booming market for weight loss and diabetes drugs.Original Article